Observational × Myelodysplastic Syndromes × Other hematologic neoplasm × Clear all ACROBAT
Active not recruiting
307 enrolled
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Recruiting
1,000 enrolled
MDS & PRRT
Recruiting
45 enrolled
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Active not recruiting
80 enrolled
NICHE
Recruiting
2,300 enrolled
Biology Studies of Hematologic Cancers
Enrolling by invitation
550 enrolled
ENKLA-M
Not yet recruiting
55 enrolled
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Recruiting
510 enrolled
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Active not recruiting
144 enrolled
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Active not recruiting
100 enrolled
Activity Levels in Bone Marrow Transplant Patients
Recruiting
200 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
REBOUND
Completed
126 enrolled
HALO-SCT
Recruiting
1,000 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
MRD
Recruiting
400 enrolled
HOPE
Recruiting
10 enrolled
Muscle Dysfunction in Patients With Haematological Diseases
Active not recruiting
216 enrolled
Connect® Myeloid Disease Registry
Terminated
2,013 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
CHIS
Not yet recruiting
1,000 enrolled
SANGUINE
Recruiting
3,000 enrolled
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Completed
81 enrolled
Blood Samples to Identify Biomarkers of Busulfan
Terminated
139 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
CYTOK-AZA
Recruiting
60 enrolled
Myeloproliferative Neoplasms (MPNs) Patient Registry
Recruiting
5,000 enrolled
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active not recruiting
9,000 enrolled
CER
Recruiting
15,000 enrolled
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Recruiting
237 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
Registry on Hypomethylating Agents in Myeloid Neoplasms
Completed
1,500 enrolled
EMATO0113
Completed
141 enrolled
BMP-MDS
Not yet recruiting
60 enrolled
Chemobrain
Completed
45 enrolled 10 charts
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
Completed
11 enrolled
DIM Vidaza
Completed
290 enrolled
DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US
Withdrawn
AML-MDS Novel Prognostic Tests Clinical Study
Completed
11 enrolled
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Completed
84 enrolled
(ANSWer)
Completed
119 enrolled
BUFLU
Completed
143 enrolled
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Withdrawn
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Completed
11 enrolled
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed
11 enrolled
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Completed
503 enrolled
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
Unknown
191 enrolled
GAH
Completed
363 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
Completed
703 enrolled 8 charts